Consolidated Statements of Redeemable Preferred Stock and Changes in Stockholders' Equity - USD ($)	Series B Preferred Stock	Series C Preferred Stock	Series A Preferred Stock	Series X Preferred Stock	Common Stock	Treasury Stock	Additional Pain-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2021			$ 55	$ 1	$ 10		$ 42,878,890	$ (10,213,196)	$ 32,665,760
Balance (in Shares) at Dec. 31, 2021			552,000	2,000	102,205
Settlement of stock in connection with prior acquisition (Note 2)
Settlement of stock in connection with prior acquisition (Note 2) (in Shares)					(3,200)
Common shares repurchased						$ (149,686)			(149,686)
Common shares repurchased (in Shares)						908
Reissuance of preferred stock
Reissuance of preferred stock (in Shares)				8,000
Common stock issued in public offering, net of costs							1,092,000		1,092,000
Common stock issued in public offering, net of costs (in Shares)					3,200
Common stock issued in public offering (ATM), net of costs					$ 1		929,735		929,736
Common stock issued in public offering (ATM), net of costs (in Shares)					6,438
Stock-based compensation							720,402	0	720,402
Stock-based compensation (in Shares)					1,660
Dividends paid to preferred shareholder								(1,449,000)	(1,449,000)
Cancellation of restricted stock
Cancellation of restricted stock (in Shares)					(892)
Net loss								(16,575,317)	(16,575,317)
Balance at Dec. 31, 2022			$ 55	$ 1	$ 11	$ (149,686)	45,621,027	(28,237,513)	17,233,895
Balance (in Shares) at Dec. 31, 2022			552,000	(10,000)	109,411	908
Common stock issued in public offering, net of costs					$ 27		9,417,246		9,417,273
Common stock issued in public offering, net of costs (in Shares)					262,534
Common and Preferred stock issued for acquisitions (Note 2) acquisition	$ 3,712,500	$ 1,063,989			$ 3		4,029,997		4,030,000
Common and Preferred stock issued for acquisitions (Note 2) acquisition (in Shares)	1,250,000	399,996			31,000
Common stock issued in settlement							39,000		39,000
Common stock issued in settlement (in Shares)					2,000
Common stock issued in connection for conversion of debt					$ 4		767,496		767,500
Common stock issued in connection for conversion of debt (in Shares)					40,161
Exercise of prefunded warrants					$ 125		(125)
Exercise of prefunded warrants (in Shares)					1,234,468
Common stock issued in public offering (ATM), net of costs					$ 1		2,246,801		2,246,802
Common stock issued in public offering (ATM), net of costs (in Shares)					14,546
Stock-based compensation							679,551	0	679,551
Stock-based compensation (in Shares)					15,737
Dividends paid to preferred shareholder								(1,618,981)	(1,618,981)
Cancellation of restricted stock					$ (3)		515,945		515,942
Cancellation of restricted stock (in Shares)					(31,002)
Net loss								(13,203,852)	(13,203,852)
Balance at Dec. 31, 2023	$ 3,712,500	$ 1,063,989	$ 55	$ 1	$ 168	$ (149,686)	$ 63,316,938	$ (43,060,346)	$ 20,107,130
Balance (in Shares) at Dec. 31, 2023	1,250,000	399,996	552,000	10,000	1,678,855	908